DAA2027 |
DNA damage acummulates in hematopoietic stem and progenitor cells |
— |
hematopoietic stem cells |
Human |
|
DAA2035 |
Alterations in frequency, developmental potential and gene expression profile in hematopoietic stem cells |
— |
hematopoietic stem cells |
Human |
|
DAA1991 |
Hematopoietic cells accumulate random mutations |
— |
hematopoietic stem cells |
Human |
|
DAA932 |
Renewal capacity declines |
— |
hematopoietic stem cells |
Human |
|
DAA2014 |
Microsatellite instability in hematopoietic stem cells and progenitor cells |
— |
hematopoietic stem cells |
Human |
|
DAA678 |
Capacity of mesenchymal stem cells to differentiate into osteoblasts may be decreased |
— |
mesenchymal stem cell |
Human |
|
DAA2013 |
Number and differentiation potential of adipose tissue-derived stem cells declines with age |
— |
mesenchymal stem cell |
Human |
|
DAA676 |
Proliferation rate of mesenchymal stem cells is reduced |
— |
mesenchymal stem cell |
Human |
|
DAA677 |
Proportion of apoptotic cells may be increased |
— |
mesenchymal stem cell |
Human |
|
DAA675 |
Beta-galactosidase expression increases in mesenchymal stem cells |
— |
mesenchymal stem cell |
Human |
|
DAA2593 |
Glycosylation of immunoglobulin G molecules changes with age |
— |
blood |
Human |
|
DAA968 |
Chronic inflammation increases |
— |
blood, immune system |
Human |
|
DAA2597 |
Mitochondrial DNA content in non-centenerians decreases with age |
— |
blood |
Human |
|
DAA2058 |
Mosaic abnormalities increase |
— |
blood, oral cavity |
Human |
|
DAA2018 |
Blood volume per unit of body weight unchanged |
— |
blood |
Human |
|
DAA2015 |
Regulation of the acid-base equilibrium of the blood unchanged |
— |
blood |
Human |
|
DAA2022 |
Prolactin decreases in females |
— |
plasma |
Human |
|
DAA1221 |
Morning concentration of sex-hormone binding globulin declines |
— |
plasma |
Human |
|
DAA1180 |
Morning concentrations of testosterone decline |
80.0% Decrease Hormone Level |
plasma |
Human |
|
DAA1215 |
Higher adrenocroticotropic hormone levels |
— |
plasma |
Human |
|
DAA917 |
Plasma and urinary catecholamine elevation after stimuli |
— |
plasma |
Human |
|
DAA1214 |
Circadian prolactin flattened |
— |
plasma |
Human |
|
DAA1212 |
Circadian plasma melatonin flattened |
— |
plasma |
Human |
|
DAA1213 |
Circadian GH change |
— |
plasma |
Human |
|
DAA910 |
DHEA levels decrease |
— |
plasma |
Human |
|